✦ LIBER ✦

The use of drotrecogin alfa recombinant activated protein C for severe sepsis in the critically burned patient: A new treatment approach

✍ Scribed by Jennifer Weintraub; Thomas Satterwhite; Maria Allo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost effectiveness of drotrecogin alfa (

✍ A. Davies; S. Ridley; J. Hutton; C. Chinn; B. Barber; D. C. Angus 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

PIN4 COST-EFFECTIVENESS OF DROTRECOGIN A

✍ JA Sacristán; L Prieto; T Huete; A Artigas; X Badia; C Chinn; P Hudson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Patient-specific decision modeling to gu

✍ Daniel P. Schauer; Anthony C. Leonard; Richard W. Hornung; Joseph A. Johnston; M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 554 KB

Use of Drotrecogin Alpha (Recombinant Hu

✍ T. Grochowiecki; S. Nazarewski; J. Meszaros; A. Kanski; M. Wojtaszek; C. Kosinsk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Cost-effectiveness of recombinant human

✍ Robert A Fowler; Marya Hill-Popper; John Stasinos; Constantia Petrou; Gillian D 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Cost-effectiveness of recombinant human

✍ Adam R Topp 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 43 KB